Advisory Research’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,559
| Closed | -$813K | – | 162 |
|
|
2024
Q2 | $813K | Buy |
5,559
+653
| +13% | +$97.1K | 0.15% | 115 |
|
|
2024
Q1 | $776K | Sell |
4,906
-274
| -5% | -$43.6K | 0.15% | 114 |
|
|
2023
Q4 | $812K | Sell |
5,180
-3,478
| -40% | -$533K | 0.13% | 185 |
|
|
2023
Q3 | $1.35M | Sell |
8,658
-1,774
| -17% | -$293K | 0.19% | 152 |
|
|
2023
Q2 | $1.73M | Buy |
10,432
+687
| +7% | +$111K | 0.22% | 122 |
|
|
2023
Q1 | $1.51M | Buy |
9,745
+13
| +0.1% | +$2.1K | 0.25% | 101 |
|
|
2022
Q4 | $1.72M | Sell |
9,732
-108
| -1% | -$18.6K | 0.16% | 97 |
|
|
2022
Q3 | $1.61M | Sell |
9,840
-130
| -1% | -$22K | 0.16% | 109 |
|
|
2022
Q2 | $1.77M | Buy |
9,970
+3
| +0% | +$535 | 0.17% | 91 |
|
|
2022
Q1 | $1.77M | Buy |
9,967
+264
| +3% | +$44.9K | 0.14% | 115 |
|
|
2021
Q4 | $1.66M | Sell |
9,703
-112,259
| -92% | -$18.4M | 0.13% | 138 |
|
|
2021
Q3 | $19.7M | Buy |
121,962
+36,508
| +43% | +$6.23M | 1.26% | 15 |
|
|
2021
Q2 | $14.1M | Sell |
85,454
-162
| -0.2% | -$26.8K | 0.93% | 26 |
|
|
2021
Q1 | $14.1M | Sell |
85,616
-2,938
| -3% | -$475K | 0.99% | 26 |
|
|
2020
Q4 | $13.9M | Sell |
88,554
-6,739
| -7% | -$994K | 1.02% | 30 |
|
|
2020
Q3 | $14.2M | Sell |
95,293
-14,903
| -14% | -$2.21M | 1.38% | 17 |
|
|
2020
Q2 | $15.5M | Sell |
110,196
-129,295
| -54% | -$18.8M | 1.38% | 17 |
|
|
2020
Q1 | $31.4M | Buy |
239,491
+3,277
| +1% | +$465K | 2.18% | 8 |
|
|
2019
Q4 | $34.5M | Sell |
236,214
-10,290
| -4% | -$1.4M | 1.58% | 12 |
|
|
2019
Q3 | $31.9M | Buy |
246,504
+402
| +0.2% | +$53K | 1.54% | 15 |
|
|
2019
Q2 | $34.3M | Sell |
246,102
-2,372
| -1% | -$328K | 0.67% | 37 |
|
|
2019
Q1 | $34.7M | Buy |
248,474
+1,602
| +0.6% | +$215K | 0.67% | 33 |
|
|
2018
Q4 | $31.9M | Buy |
246,872
+119,923
| +94% | +$16.7M | 0.67% | 34 |
|
|
2018
Q3 | $17.5M | Sell |
126,949
-9,271
| -7% | -$1.23M | 0.29% | 89 |
|
|
2018
Q2 | $16.5M | Sell |
136,220
-247,294
| -64% | -$30.9M | 0.26% | 100 |
|
|
2018
Q1 | $49.1M | Buy |
383,514
+5,982
| +2% | +$809K | 0.88% | 29 |
|
|
2017
Q4 | $52.7M | Buy |
377,532
+5,292
| +1% | +$737K | 0.87% | 30 |
|
|
2017
Q3 | $48.4M | Buy |
372,240
+101,977
| +38% | +$13.5M | 0.77% | 37 |
|
|
2017
Q2 | $35.8M | Buy |
270,263
+164,068
| +154% | +$20.9M | 0.56% | 48 |
|
|
2017
Q1 | $13.2M | Buy |
106,195
+97,565
| +1,131% | +$11.7M | 0.19% | 95 |
|
|
2016
Q4 | $994K | Sell |
8,630
-12,010
| -58% | -$1.39M | 0.01% | 280 |
|
|
2016
Q3 | $2.44M | Sell |
20,640
-432
| -2% | -$52.4K | 0.04% | 136 |
|
|
2016
Q2 | $2.56M | Sell |
21,072
-12,781
| -38% | -$1.45M | 0.04% | 141 |
|
|
2016
Q1 | $3.66M | Sell |
33,853
-40,613
| -55% | -$4.2M | 0.07% | 129 |
|
|
2015
Q4 | $7.65M | Sell |
74,466
-42,194
| -36% | -$4.24M | 0.12% | 135 |
|
|
2015
Q3 | $10.9M | Sell |
116,660
-849
| -0.7% | -$82.1K | 0.16% | 140 |
|
|
2015
Q2 | $11.5M | Sell |
117,509
-7,445
| -6% | -$746K | 0.13% | 153 |
|
|
2015
Q1 | $12.6M | Sell |
124,954
-21,890
| -15% | -$2.23M | 0.14% | 138 |
|
|
2014
Q4 | $15.4M | Sell |
146,844
-12,567
| -8% | -$1.32M | 0.16% | 130 |
|
|
2014
Q3 | $17M | Sell |
159,411
-7,490
| -4% | -$777K | 0.16% | 123 |
|
|
2014
Q2 | $17.5M | Sell |
166,901
-54,853
| -25% | -$5.54M | 0.16% | 126 |
|
|
2014
Q1 | $21.8M | Sell |
221,754
-8,807
| -4% | -$817K | 0.22% | 104 |
|
|
2013
Q4 | $21.1M | Sell |
230,561
-4,579
| -2% | -$422K | 0.22% | 114 |
|
|
2013
Q3 | $20.4M | Buy |
235,140
+1,090
| +0.5% | +$97.8K | 0.22% | 117 |
|
|
2013
Q2 | $20.1M | Buy |
+234,050
| New | +$19.9M | 0.23% | 113 |
|
Other funds holding JNJ
Advisory Research's JNJ Position: Q3 2024 in Review
Advisory Research sold out of Johnson & Johnson (JNJ) in Q3 2024, closing a stake of 5,559 shares — an estimated $813K sold.
Advisory Research first reported a position in JNJ in Q2 2013 and held it in 45 quarters. The position peaked at $52.7M in Q4 2017. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.
- Advisory Research reported no remaining Johnson & Johnson position as of Q3 2024 after selling out during the quarter.
- Advisory Research sold 5,559 Johnson & Johnson shares in Q3 2024, an estimated $813K.
- Advisory Research first reported a position in Johnson & Johnson in Q2 2013 and held it in 45 quarters.
- Advisory Research's Johnson & Johnson position peaked at $52.7M in Q4 2017.
- 3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.
Based on Advisory Research's 13F filing for Q3 2024, filed 14 Nov 2024.